• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷瘤小鼠血浆中纤连蛋白的浓度及艾氏腹水癌细胞的合成。

Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells.

作者信息

Zardi L, Cecconi C, Barbieri O, Carnemolla B, Picca M, Santi L

出版信息

Cancer Res. 1979 Sep;39(9):3774-9.

PMID:383288
Abstract

In the present paper we have studied: (a) the concentration of fibronectin (FN) in plasma and in ascitic fluid of mice at different times after inoculation of Ehrlich ascites tumor cells; (b) the ability of Ehrlich ascites cells to synthesize and release FN; and (c) the localization of FN in Ehrlich ascites cells by immunofluorescence microscopy. It was found that (a) 4 to 5 days after inoculation of the tumor, the plasma concentration of FN was significantly higher [1.7 +/- 0.07% (S.E.) of total plasma protein] than that in the normal control mice (0.8 +/- 0.035); (b) FN is present in the ascitic fluid in all phases of tumor growth; (c) Ehrlich ascites cells cultured in vitro synthesize and release large amounts of FN in the culture medium; and (d) only about 1 to 2% of the tumor cells show a very small amount of FN, and this is mostly in the area of cell-cell contact.

摘要

在本论文中,我们研究了:(a)接种艾氏腹水癌细胞后不同时间小鼠血浆和腹水中纤连蛋白(FN)的浓度;(b)艾氏腹水细胞合成和释放FN的能力;以及(c)通过免疫荧光显微镜观察FN在艾氏腹水细胞中的定位。结果发现:(a)接种肿瘤4至5天后,血浆中FN的浓度[占总血浆蛋白的1.7±0.07%(标准误)]显著高于正常对照小鼠(0.8±0.035);(b)在肿瘤生长的各个阶段腹水中均存在FN;(c)体外培养的艾氏腹水细胞在培养基中合成并释放大量FN;以及(d)仅约1%至2%的肿瘤细胞显示出极少量的FN,且大多位于细胞-细胞接触区域。

相似文献

1
Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells.荷瘤小鼠血浆中纤连蛋白的浓度及艾氏腹水癌细胞的合成。
Cancer Res. 1979 Sep;39(9):3774-9.
2
Proteases during the growth of Ehrlich ascites tumor. I. The fibrinolysin system.艾氏腹水瘤生长过程中的蛋白酶。一、纤维蛋白溶解酶系统。
J Natl Cancer Inst. 1975 Apr;54(4):881-6.
3
Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
Neoplasma. 1983;30(2):147-52.
4
[The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].[腹水对艾氏腹水癌和刘易斯肺癌生长的影响]
Biull Eksp Biol Med. 1992 Jul;114(8):191-3.
5
[The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].[艾氏腹水癌和畸胎瘤T-36伴腹水及肿瘤细胞透析液生长的模型构建]
Biull Eksp Biol Med. 1992 Jul;114(8):193-5.
6
Chalone-like inhibition of Ehrlich ascites cell proliferation in vitro by an ultrafiltrate obtained from the ascitic fluid.腹水超滤液对艾氏腹水癌细胞体外增殖的类抑素样抑制作用。
Acta Biol Med Ger. 1977;36(7-8):K 43-52.
7
[3H-thymidine incorporation into the DNA of the nucleic factor in the ascitic fluid of Ehrlich cancer].
Eksp Onkol. 1985;7(6):50-3.
8
Expression and function of beta 1 integrins on adherent and nonadherent Ehrlich ascites tumor cells.β1整合素在贴壁和非贴壁艾氏腹水瘤细胞上的表达及功能
Exp Cell Res. 1995 May;218(1):96-104. doi: 10.1006/excr.1995.1135.
9
Purine nucleotide levels in host tissues of Ehrlich ascites tumor-bearing mice in different growth phases of the tumor.艾氏腹水瘤荷瘤小鼠宿主组织在肿瘤不同生长阶段的嘌呤核苷酸水平。
Cancer Res. 1993 Nov 1;53(21):5143-7.
10
Changes in lipoprotein lipase activity (LPLA) in tumor cells and tissues in mice bearing Ehrlich ascites tumor.荷艾氏腹水瘤小鼠肿瘤细胞和组织中脂蛋白脂肪酶活性(LPLA)的变化
Bull Cancer. 1984;71(5):412-8.

引用本文的文献

1
Fibronectin degradation as biomarker for infection and treatment monitoring in mice.纤维连接蛋白降解作为小鼠感染和治疗监测的生物标志物。
Parasitology. 2021 Aug;148(9):1067-1073. doi: 10.1017/S0031182021000809. Epub 2021 May 24.
2
Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology.纤连蛋白作为肿瘤基质中至关重要的多调节分子:从结构和功能特征到肿瘤学临床实践
J Exp Clin Cancer Res. 2021 Mar 17;40(1):102. doi: 10.1186/s13046-021-01908-8.
3
Stromal Protein-Mediated Immune Regulation in Digestive Cancers.
基质蛋白介导的消化系统癌症免疫调节
Cancers (Basel). 2021 Jan 5;13(1):146. doi: 10.3390/cancers13010146.
4
Controlling Fibronectin Fibrillogenesis Using Visible Light.利用可见光控制纤连蛋白原纤维形成
Front Mol Biosci. 2020 Jul 8;7:149. doi: 10.3389/fmolb.2020.00149. eCollection 2020.
5
Plasma-Coated Polycaprolactone Nanofibers with Covalently Bonded Platelet-Rich Plasma Enhance Adhesion and Growth of Human Fibroblasts.共价结合富血小板血浆的等离子体涂层聚己内酯纳米纤维可增强人成纤维细胞的黏附与生长。
Nanomaterials (Basel). 2019 Apr 19;9(4):637. doi: 10.3390/nano9040637.
6
Roles of fibronectin isoforms in neonatal vascular development and matrix integrity.纤维连接蛋白异构体在新生儿血管发育和基质完整性中的作用。
PLoS Biol. 2018 Jul 23;16(7):e2004812. doi: 10.1371/journal.pbio.2004812. eCollection 2018 Jul.
7
Cancer Cells Elimination Guided by Aptamer-Functionalized Gold-Coated Magnetic Nanoparticles and Controlled with Low Frequency Alternating Magnetic Field.适配体功能化金包覆磁性纳米颗粒引导的癌细胞消除及其低频交变磁场控制。
Theranostics. 2017 Jul 30;7(13):3326-3337. doi: 10.7150/thno.17089. eCollection 2017.
8
Fibronectin Mechanobiology Regulates Tumorigenesis.纤连蛋白力学生物学调控肿瘤发生。
Cell Mol Bioeng. 2016;9:1-11. doi: 10.1007/s12195-015-0417-4. Epub 2015 Aug 15.
9
Plasma and cellular fibronectin: distinct and independent functions during tissue repair.血浆和细胞纤连蛋白:组织修复过程中的不同且独立的功能。
Fibrogenesis Tissue Repair. 2011 Sep 16;4:21. doi: 10.1186/1755-1536-4-21.
10
Plasma fibronectin concentration in inbred mouse strains.近交系小鼠品系中的血浆纤连蛋白浓度。
Thromb Haemost. 2009 Dec;102(6):1278-80. doi: 10.1160/TH09-03-0141.